Your browser doesn't support javascript.
loading
The third model of Bax/Bak activation: a Bcl-2 family feud finally resolved?
Luo, Xu; O'Neill, Katelyn L; Huang, Kai.
Afiliação
  • Luo X; Eppley Institute for Research in Cancer and Allied Diseases, Fred & Pamela Buffett Cancer Center, University of Alaska Medical Center, Omaha, ME, 68198-7696, USA.
  • O'Neill KL; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, 68198-6805, USA.
  • Huang K; Eppley Institute for Research in Cancer and Allied Diseases, Fred & Pamela Buffett Cancer Center, University of Alaska Medical Center, Omaha, ME, 68198-7696, USA.
F1000Res ; 92020.
Article em En | MEDLINE | ID: mdl-32802314
Bax and Bak, two functionally similar, pro-apoptotic proteins of the Bcl-2 family, are known as the gateway to apoptosis because of their requisite roles as effectors of mitochondrial outer membrane permeabilization (MOMP), a major step during mitochondria-dependent apoptosis. The mechanism of how cells turn Bax/Bak from inert molecules into fully active and lethal effectors had long been the focal point of a major debate centered around two competing, but not mutually exclusive, models: direct activation and indirect activation. After intensive research efforts for over two decades, it is now widely accepted that to initiate apoptosis, some of the BH3-only proteins, a subclass of the Bcl-2 family, directly engage Bax/Bak to trigger their conformational transformation and activation. However, a series of recent discoveries, using previously unavailable CRISPR-engineered cell systems, challenge the basic premise that undergirds the consensus and provide evidence for a novel and surprisingly simple model of Bax/Bak activation: the membrane (lipids)-mediated spontaneous model. This review will discuss the evidence, rationale, significance, and implications of this new model.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas c-bcl-2 / Proteína X Associada a bcl-2 / Proteína Killer-Antagonista Homóloga a bcl-2 Limite: Humans Idioma: En Revista: F1000Res Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas c-bcl-2 / Proteína X Associada a bcl-2 / Proteína Killer-Antagonista Homóloga a bcl-2 Limite: Humans Idioma: En Revista: F1000Res Ano de publicação: 2020 Tipo de documento: Article